Display Single Record

FOI Request

Disclosure ID
FOI/00803
Request Date
February 5, 2016
Subject
Biosimilar Infliximab
Description

1. Does your trust treat patients with biosimilar infliximab, either Remsima or Inflectra?

2. If your trust does treat patients with a biosimilar, how many patients are currently being treated?

 

3. If your trust does NOT treat patients with a biosimilar, do you plan to start using them?

Response

1. No

 

2. Not applicable

 

3. We are in the process of discussing with commissioners.

Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
Attachment 6
Attachment 7
Attachment 8
Attachment 9